Corporate medicine is hijacking feminist narratives around empowerment and women’s rights to market technologies, tests and treatments that aren’t backed by evidence.
Academic rigor, journalistic flair
Articles on Overtreatment
Displaying 1 - 20 of 33 articles
People with low-risk prostate cancer are more likely to die from something else. Overdiagnosis and overtreatment can lead to life-changing complications.
About one in six pregnant women in Australia are now diagnosed with gestational diabetes. Rates have more than doubled since the thresholds for diagnosis were changed.
Prostate cancer is one of the most common cancers in men. Although watchful waiting is appropriate for low-risk cases, many are diagnosed at an advanced stage because of racial health disparities.
More and more healthy women and men are found to have thyroid nodules. What are they? And should you be worried about them?
As access to health care increases, there’s also a danger of getting too much of it.
These 3 common surgeries have been found to be of little to no benefit, but thousands are still performed every year.
With more than 850 changes to Medicare on the cards, the system needs time to adjust. Hasty implementation may mean patients face higher gap fees.
Our new study shows a widely used fertility treatment, known as ICSI, is no better than standard IVF for most people. Yet, it’s being routinely offered around the world.
How do you know if your child’s behaviour is normal or a sign of ADHD? The answer is not so clear cut. And now we have the evidence to show the consequences.
Health professionals should carefully consider the terms they use to avoid needless anxiety and unnecessary surgeries.
Once his leg fracture heals, his leg can potentially be just as straight and strong as it was before. But his foot and ankle are more of a worry.
Elective surgeries have been halted as part of the health system’s response to coronavirus. But many are unnecessary and shouldn’t be rescheduled after the pandemic ends.
Last month, Australia announced a pause on all elective surgeries. This could have mixed effects now and in the longer term.
Just under one in six Australian women have PCOS but some are being diagnosed when they don’t meet the criteria.
New research estimates 24% of cancers in men that were detected in 2012 were overdiagnosed, meaning they never would have caused harm if left untreated.
Too often, pharmaceutical companies and device manufacturers exert influence in how their products are tested in the research phase and recommended in the clinic.
One in four Australians is overweight or obese by the time they reach adolescence, but it’s difficult to predict who is at risk. These three questions can help.
Rates of elective surgery are rising most among those aged over 85, due to advances in anaesthesia and techniques such as keyhole surgery. But it’s also much riskier.
New tests may mean more people are diagnosed, but that doesn’t mean they’ll be helped by the label or the treatment. Here are five markers that overdiagnosis may be occuring.
Top contributors
-
Assistant Professor, Bond University
-
Professor of Public Health, University of Sydney
-
NHMRC Emerging Leader Research Fellow, University of Sydney
-
Professor of Medicine, Bond University
-
Professor of Clinical Epidemiology, Sydney School of Public Health, University of Sydney
-
Professor of Clinical Epidemiology, Bond University
-
Clinical Professorial Research Fellow, Australian Women and Girls' Health Research Centre, The University of Queensland
-
Professor of Orthopaedic Surgery, UNSW Sydney
-
Professor of Public Health, Bond University
-
NHMRC Emerging Leader Research Fellow, University of Sydney
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
NHMRC Emerging Leader Research Fellow, Sydney Musculoskeletal Health, University of Sydney
-
NHMRC Emerging Leader Research Fellow, Institute of Musculoskeletal Health, University of Sydney
-
NHMRC Principal Research Fellow, University of Sydney
-
Postdoctoral Research Fellow, University of Sydney
